Panagora Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Panagora Asset Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,879	Closed	-$338K	–	2660
2019 Q1	$338K	Buy	+4,879	New	+$279K	﹤0.01%	1532
2015 Q2	–	Sell	-496	Closed	-$31K	–	2462
2015 Q1	$31K	Buy	+496	New	+$27.6K	﹤0.01%	2150
2014 Q4	–	Sell	-25,292	Closed	-$1.43M	–	2333
2014 Q3	$1.43M	Sell	25,292 -282	-1%	-$14.2K	0.01%	881
2014 Q2	$1.15M	Sell	25,574 -1,389	-5%	-$57.2K	0.01%	1055
2014 Q1	$1.32M	Buy	+26,963	New	+$1.39M	0.01%	1057

Other funds holding RARE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Panagora Asset Management's RARE Position: Q2 2019 in Review

Panagora Asset Management sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2019, closing a stake of 4,879 shares — an estimated $338K sold.

Panagora Asset Management first reported a position in RARE in Q1 2014 and held it in 5 quarters. The position peaked at $1.43M in Q3 2014. 170 funds tracked by Wall St. Rank hold RARE as of Q2 2019.

Panagora Asset Management reported no remaining Ultragenyx Pharmaceutical position as of Q2 2019 after selling out during the quarter.
Panagora Asset Management sold 4,879 Ultragenyx Pharmaceutical shares in Q2 2019, an estimated $338K.
Panagora Asset Management first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 5 quarters.
Panagora Asset Management's Ultragenyx Pharmaceutical position peaked at $1.43M in Q3 2014.
170 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2019.

Based on Panagora Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.